Review shows benefits for social responsiveness, disruptive behavior, and anxiety
Additionally, specific symptom improvement seen
Commercial administrative claims data show slight increase in annual prevalence from 2015 to 2020
Findings persist across various periods
Risk for death higher for individuals with hospital-based care for alcohol, stimulant, opioids versus cannabis use disorder
Schizophrenia-associated increase seen from prelegalization to legalization of nonmedical cannabis periods
Anterior insula, medial prefrontal cortex, and dorsolateral prefrontal cortex associated with history of heavy use
Findings seen for younger adults across cannabis use disorder severity levels
For individuals reporting past-year cannabis use, decreased odds of opioid misuse observed in states with medical cannabis legalization
Increase in cannabis poisoning seen with medical cannabis laws and recreational cannabis laws